Different Positions of the Impella Device Between the Axillary and Femoral Approaches

IF 1.1 Circulation reports Pub Date : 2022-02-19 DOI:10.1253/circrep.cr-21-0164

Y. Nishimoto, K. Okayama, M. Toma, Yukihito Sato

引用次数: 0

Abstract

Received January 6, 2022; accepted February 8, 2022; J-STAGE Advance Publication released online February 19, 2022 Time for primary review: 33 days Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki (Y.N., M.T., Y.S.); Department of Cardiology, Osaka University Graduate School of Medicine, Osaka (K.O.), Japan Mailing address: Yuji Nishimoto, MD, Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77 Higashinaniwa-cho, Amagasaki 660-8550, Japan. E-mail: yuji.nishimoto@gmail.com All rights are reserved to the Japanese Circulation Society. For permissions, please e-mail: cr@j-circ.or.jp ISSN-2434-0790 Different Positions of the Impella Device Between the Axillary and Femoral Approaches

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

腋窝入路与股骨入路的不同位置的Impella装置

2022年1月6日收到;2022年2月8日接受;J-STAGE Advance Publication于2022年2月19日在线发布初步审查时间:33天兵库县amasaki综合医疗中心心内科，amasaki (Y.N.， m.t.， Y.S.);邮寄地址:西本裕二医学博士，兵库县长崎市综合医疗中心心脏病科，2-17-77东谷町，长崎市660-8550，日本。电子邮件:yuji.nishimoto@gmail.com所有权利归日本流通学会所有。征求许可，请发送电子邮件:cr@j-circ.or.jp ISSN-2434-0790腋窝入路和股动脉入路之间Impella装置的不同位置

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Circulation reports

自引率

0.00%

发文量

期刊最新文献

Impact of Snowfall on Ambulance Response Times to Out-of-Hospital Cardiac Arrest　- Nationally-Representative Population-Based Registry Analysis, 2009-2019. Significance of Prehospital 12-Lead Electrocardiogram Transmission　- Trial Utilizing an Established Smartphone Communication Application for Acute Stroke Management. Japanese Nationwide Survey of New Heart Failure Drug Prescriptions by Pediatric Cardiologists. Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study　- Rationale and Study Design. Evaluation of the 1-Year Efficacy and Tolerability of Inclisiran in Coronary Artery Disease Patients.